Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00782366 · ClinicalTrials.gov registry record
Predictive Genetic Risk Assessment Trial
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 26
- Enrollment target
NCT00782366: Completed study, sponsored by Mayo Clinic.
NCT00782366 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00782366 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
Study Summary
This proof-of-principle clinical trial at Mayo Clinic studies how patients and their physicians understand and utilize predictive genetic risk assessment. A critical goal of this clinical trial is to understand how individual patients and their doctors perceive and respond to genetic risk information that is largely uncertain.
Interventions
- GENETIC SNP analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00782366
The ClinicalTrials.gov registry entry for NCT00782366 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SNP analysis is the first listed.
NCT00782366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00782366 about?
NCT00782366 is a clinical study titled "Predictive Genetic Risk Assessment Trial". This proof-of-principle clinical trial at Mayo Clinic studies how patients and their physicians understand and utilize predictive genetic risk assessment. A critical goal of this clinical trial is to understand how individual patients and their doctors perceive and respond to genetic risk informatio...
What is the current status of trial NCT00782366?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2008-03. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00782366?
The interventions under investigation include: SNP analysis (GENETIC).
Who is sponsoring clinical trial NCT00782366?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.